Moolec Science于2026年1月5日完成了15换1的股票整合，更新了股票代码和CUSIP，且未经过股东行动。 Moolec Science completed a 15-for-1 share consolidation on Jan. 5, 2026, updating its ticker and CUSIP without shareholder action.

Moolec Science于2026年1月5日完成了15对1股份的合并,将未清股份从10 891 761个减少到726 118个,不需要股东采取任何行动。 Moolec Science completed a 15-for-1 share consolidation on January 5, 2026, reducing outstanding shares from 10,891,761 to 726,118, with no action needed from shareholders. 该变化于东部时间上午8时生效,更新了“MLEC”字标为新的CUSIP(G6223S 125),同时根据同一CUSIP的“MLECW”号继续发出逮捕令。 The change, effective at 8:00 a.m. Eastern Time, updated the ticker symbol "MLEC" to a new CUSIP (G6223S 125), while warrants continue under "MLECW" with the same CUSIP. 这种合并并不影响公司的业务或战略。 The consolidation does not affect the company’s operations or strategy. 通过分子耕作和精确发酵开发可持续蛋白质的Moolec科学仍然列在Nasdaq上,拥有118个专利。 Moolec Science, which develops sustainable proteins via molecular farming and precision fermentation, remains listed on Nasdaq and holds over 118 patents. 发布说明中的前瞻性声明与市场条件、规章和规模有关的风险。 Forward-looking statements in the release note risks related to market conditions, regulations, and scaling.